Review of the treatment of psoriatic arthritis with biological agents: choice of drug for initial therapy and switch therapy for non-responders
Salvatore D’Angelo,1 Giuseppina Tramontano,1 Michele Gilio,1 Pietro Leccese,1 Ignazio Olivieri1,2 1Rheumatology Institute of Lucania (IRel) - Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza and Matera, 2Basilicata Ricer...
Main Authors: | D'Angelo S, Tramontano G, Gilio M, Leccese P, Olivieri I |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-03-01
|
Series: | Open Access Rheumatology : Research and Reviews |
Subjects: | |
Online Access: | https://www.dovepress.com/review-of-the-treatment-of-psoriatic-arthritis-with-biological-agents--peer-reviewed-article-OARRR |
Similar Items
-
New approved drugs for psoriatic arthritis
by: F.M. Perrotta, et al.
Published: (2016-09-01) -
New-onset vitiligo as an unusual cutaneous reaction under ustekinumab therapy in patients with psoriatic arthritis
by: Onur Kaan Gedikli, et al.
Published: (2020-10-01) -
Real Life Efficacy and Safety of Secukinumab in Biologic-Experienced Patients With Psoriatic Arthritis
by: Kalliopi Klavdianou, et al.
Published: (2020-06-01) -
Cost-effectiveness analysis of active psoriatic arthritis treatment with ixekizumab in adult patients in Russian Federation health care system
by: E. A. Pyadushkina, et al.
Published: (2021-02-01) -
Experience in using secukinumab in patients with axial psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2020-11-01)